RxDoctor Payments Data

Neal Lawrence, MD

Family Medicine · Eureka Springs, ARNPI 1518934314

Payments from drug & device makers

$6,044in general payments, 2019–2025

Across 412 payments — averaging $14.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Merck$537
  • Pfizer$536
  • Novo Nordisk$406
  • GSK$354
  • Biohaven Pharmaceutical Holding Company Ltd.$243
  • plus $3K from 42 others

What the payments were for

  • Consulting fees$150%
  • Food & beverage$5,813100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,044 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$85,469
Medicare patients
419
Services billed
3,644

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$57,093
EliquisApixaban52$46,770
MounjaroTirzepatide41$44,224
TrulicityDulaglutide24$33,123
JanuviaSitagliptin Phosphate34$30,869
JardianceEmpagliflozin23$24,278
XareltoRivaroxaban22$19,425
NeuproRotigotine11$14,554
FarxigaDapagliflozin Propanediol11$9,778
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,119
Breo ElliptaFluticasone/Vilanterol12$6,654
Liothyronine Sodium162$5,655
Levothyroxine Sodium503$5,036
SteglatroErtugliflozin Pidolate12$4,314
Gabapentin170$3,272

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$90$77,34765 claims
Novo NordiskOzempic$406$57,09340 claims
PfizerEliquis$536$46,77052 claims
MerckJanuvia, Steglatro$537$35,18446 claims
Boehringer IngelheimJardiance$97$24,27823 claims
Johnson & JohnsonXarelto$92$19,42522 claims
GSKTrelegy Ellipta, Breo Ellipta$354$13,77423 claims
AstraZenecaFarxiga$155$9,77811 claims
AbbVieSynthroid, Armour Thyroid$1,241$3,94484 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Eureka Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →